Stay updated with breaking news from Hepatobiliary Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Taking a low-dose daily aspirin long-term may reduce the risk of developing or dying from colorectal cancer by revving the body's immune response to cancer cells, according to a new study.
A new study in mice found that dietary vitamin D plays a role in balancing the gut microbiome and improving the way cancer immunotherapy works to fight tumors.
Researchers say daily aspirin use can help prevent the development of colorectal cancer as well as slow disease progress. However, experts note there are some potential serious side effects of taking the pain medication every day.
A new study suggests aspirin taken over time can slow or prevent colorectal cancer by raising the body’s immune response to cancer cells.
Does low-dose aspirin reduce risk of colorectal cancer? Will low-dose aspirin stop spread? Is survival better with aspirin in colon cancer? Read more.